Plus Therapeutics (PSTV) Return on Assets (2016 - 2025)
Plus Therapeutics (PSTV) has disclosed Return on Assets for 15 consecutive years, with 0.96% as the latest value for Q3 2025.
- On a quarterly basis, Return on Assets rose 64.0% to 0.96% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.96%, a 64.0% increase, with the full-year FY2024 number at 1.62%, down 87.0% from a year prior.
- Return on Assets was 0.96% for Q3 2025 at Plus Therapeutics, up from 1.19% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.41% in Q2 2021 to a low of 2.15% in Q4 2024.
- A 5-year average of 1.07% and a median of 1.07% in 2023 define the central range for Return on Assets.
- Peak YoY movement for Return on Assets: plummeted -107bps in 2024, then soared 64bps in 2025.
- Plus Therapeutics' Return on Assets stood at 0.44% in 2021, then crashed by -98bps to 0.86% in 2022, then decreased by -25bps to 1.08% in 2023, then plummeted by -99bps to 2.15% in 2024, then surged by 55bps to 0.96% in 2025.
- Per Business Quant, the three most recent readings for PSTV's Return on Assets are 0.96% (Q3 2025), 1.19% (Q2 2025), and 1.65% (Q1 2025).